Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12018291 Compositions and methods for antigen targeting to CD180

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jay Wesley Chaplin0

Edward Clark0

Date of Patent

June 25, 2024

0

Patent Application Number

180638230

Date Filed

December 9, 2022

0

Patent Citations

US Patent 11549102 Compositions and methods for antigen targeting to CD180

0

US Patent 10196614 Compositions and methods for antigen targeting to CD180

0

US Patent 10563179 Compositions and methods for antigen targeting to CD180

0

US Patent 8058400 Composition and method for modulating dendritic cell-t cell interaction

0

US Patent 9260529 Molecules that bind CD180, compositions and methods of use

0

US Patent 9416188 Molecules that bind CD180, compositions and methods of use

0

US Patent 10196612 Method of characterizing and manipulating adipose stem cell depots to a metabolically healthy state

0

Patent Primary Examiner

Agnieszka Boesen

0

Patent abstract

The present invention provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12018291 Compositions and methods for antigen targeting to CD180

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool